Cart summary

You have no items in your shopping cart.

TBI-166

SKU: orb1744168

Description

TBI-166 is an orally bioavailable riminophenazine compound developed as a next-generation anti-tuberculosis agent. It demonstrates potent activity against Mycobacterium tuberculosis in both in vitro and in vivo models while exhibiting an improved safety profile compared to Clofazimine.

Research Area

Infectious Disease & Virology

Images & Validation

Key Properties

CAS Number1353734-12-9
MW589.61
FormulaC32H30F3N5O3
SMILESN(=C1C=C2N(C=3C(N=C2C=C1NC4=C(OC)N=CC=C4)=CC=CC3)C5=CC=C(OC(F)(F)F)C=C5)C6CCC(OC)CC6
TargetOthers,Antibacterial

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

TBI-166 (orb1744168)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%